APOE-Targeted Epigenome Therapy for Alzheimer's Disease
Publication
, Conference
Chiba-Falek, O; Kantor, B
Published in: MOLECULAR THERAPY
2022
Duke Scholars
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2022
Volume
30
Issue
4
Start / End Page
459 / 459
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Chiba-Falek, O., & Kantor, B. (2022). APOE-Targeted Epigenome Therapy for Alzheimer's Disease. In MOLECULAR THERAPY (Vol. 30, pp. 459–459).
Chiba-Falek, Ornit, and Boris Kantor. “APOE-Targeted Epigenome Therapy for Alzheimer's Disease.” In MOLECULAR THERAPY, 30:459–459, 2022.
Chiba-Falek O, Kantor B. APOE-Targeted Epigenome Therapy for Alzheimer's Disease. In: MOLECULAR THERAPY. 2022. p. 459–459.
Chiba-Falek, Ornit, and Boris Kantor. “APOE-Targeted Epigenome Therapy for Alzheimer's Disease.” MOLECULAR THERAPY, vol. 30, no. 4, 2022, pp. 459–459.
Chiba-Falek O, Kantor B. APOE-Targeted Epigenome Therapy for Alzheimer's Disease. MOLECULAR THERAPY. 2022. p. 459–459.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2022
Volume
30
Issue
4
Start / End Page
459 / 459
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences